(21R)-HYDROXY RIFABUTIN
UNII N78A2F8BV7

Substance Identification & Data

This profile provides standardized clinical and technical data for (21r)-hydroxy Rifabutin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N78A2F8BV7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 185803-93-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N78A2F8BV7

CAS Registry Number

185803-93-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

(21R)-HYDROXY RIFABUTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C46H62N4O12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

VDTSFQHFKVJUOY-KFTMIDLWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C12=C3C(c4c(C1=O)c(c(c5c4C([C@](O5)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]([C@](/C=C/C=C(\C(N2)=O)/C)(C)O)O)C)O)C)OC(=O)C)C)OC)C)=O)C)O)=NC6(N3)CCN(CC6)CC(C)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for (21r)-hydroxy Rifabutin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

(21R)-HYDROXY RIFABUTIN

Systematic Nomenclature

(9S,12E,14S,15R,16S,17R,18R,19S,20R,21R,22E,24Z)-16-(ACETYLOXY)-6,18,20,21-TETRAHYDROXY-14-METHOXY-7,9,15,17,19,21,25-HEPTAMETHYL-1'-(2-METHYLPROPYL)SPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H-FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)-5,10,26(3H,9H)-TRIONE

SYS

16-(ACETYLOXY)-6,18,20,21-TETRAHYDROXY-14-METHOXY-7,9,15,17,19,21,25-HEPTAMETHYL-1'-(2-METHYLPROPYL)SPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H-FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)-5,10,26(3H,9H)-TRIONE, (9S,12E,14S,15R,16S,17R,18R,19S,20R,21R,22E,24Z)-

SYS

SPIRO(9,4-(EPOXYPENTADECA(1,11,13)TRIENIMINO)-2H-FURO(2',3':7,8)NAPHTH(1,2-D)IMIDAZOLE-2,4'-PIPERIDINE)-5,10,26(3H,9H)-TRIONE, 16-(ACETYLOXY)-6,18,20,21-TETRAHYDROXY-14-METHOXY-7,9,15,17,19,21,25-HEPTAMETHYL-1'-(2-METHYLPROPYL)-, (9S-(9R*,12E,14R*,15S*,16R*,17S*,18S*,19R*,20S*,21S*,22E,24Z))-

SYS

External Clinical & Regulatory Resources

Previous UNIIN788AO107G

Next UNIIN78AH78WRV